Download PDF
Digestive Disease Interventions 2017; 01(02): 094-104
DOI: 10.1055/s-0037-1603811
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Role of Hepatectomy for Hepatocellular Carcinoma in the Era of Transplantation and Locoregional Therapy

Nicholas Latchana
1   Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
,
Christopher McQuinn
1   Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
,
Richard Burkhart
2   Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland
,
Samantha Lahey
1   Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
,
Timothy M. Pawlik
1   Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
› Author Affiliations
Further Information

Publication History

19 December 2016

04 May 2017

Publication Date:
08 June 2017 (online)

Also available at
    Permissions and Reprints

Abstract

Hepatocellular carcinoma (HCC) remains the most common primary liver neoplasm and is a leading cause of cancer-related mortality worldwide. Therapeutic options are increasing in HCC and now include surgical resection, transplantation, local ablation, directed transarterial therapies, and systemic therapies. Efficacy for each modality varies widely with the chance for cure dictated predominantly by disease biology. Surgical extirpation remains the mainstay of therapy in a curative paradigm. The role of hepatectomy and transplantation, however, has evolved as multidisciplinary management and now integrates other locoregional and systemic therapies. Herein, we review the modern approach to HCC within the context of historical trials. Studies informing a current practice that combine surgery with locoregional therapies are highlighted. A variety of transarterial options are critically examined and selection criteria for use are suggested. Finally, current best-practice guidelines are discussed with updates and practical advice where warranted.

Keywords

hepatocellular carcinoma - hepatectomy - liver transplantation - transarterial chemoembolization - transarterial radioembolization - sorafenib
 

  • References

  • 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66 (01) 7-30
    CrossrefPubMedGoogle Scholar
  • 2 Weinmann A, Koch S, Niederle IM. , et al. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry. J Clin Gastroenterol 2014; 48 (03) 279-289
    CrossrefPubMedGoogle Scholar
  • 3 Howlader N, Noone A, Krapcho M. , et al. SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. based on November 2014 SEER data submission, posted to the SEER web site, April 2015 . Available at: http://seer.cancer.gov/statfacts/html/pancreas.html . Accessed March 1, 2016
    PubMed
  • 4 Kim Y, Ejaz A, Tayal A. , et al. Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer 2014; 120 (19) 3058-3065
    CrossrefPubMedGoogle Scholar
  • 5 Goh GB, Chang PE, Tan CK. Changing epidemiology of hepatocellular carcinoma in Asia. Best Pract Res Clin Gastroenterol 2015; 29 (06) 919-928
    CrossrefPubMedGoogle Scholar
  • 6 Busco S, Buzzoni C, Mallone S. , et al; AIRTUM Working Group. Italian cancer figures--Report 2015: the burden of rare cancers in Italy. Epidemiol Prev 2016; 40 (01) (Suppl. 02) 1-120
    PubMedGoogle Scholar
  • 7 Mokdad AA, Lopez AD, Shahraz S. , et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 2014; 12: 145
    CrossrefPubMedGoogle Scholar
  • 8 Lee KK, Kim DG, Moon IS, Lee MD, Park JH. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol 2010; 101 (01) 47-53
    CrossrefPubMedGoogle Scholar
  • 9 Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR. Surgical management of hepatocellular carcinoma: is the jury still out?. Surg Oncol 2009; 18 (04) 298-321
    CrossrefPubMedGoogle Scholar
  • 10 Nathan H, Segev DL, Mayo SC. , et al. National trends in surgical procedures for hepatocellular carcinoma: 1998-2008. Cancer 2012; 118 (07) 1838-1844
    CrossrefPubMedGoogle Scholar
  • 11 Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235 (03) 373-382
    CrossrefPubMedGoogle Scholar
  • 12 Llovet JM, Ricci S, Mazzaferro V. , et al; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359 (04) 378-390
    CrossrefPubMedGoogle Scholar
  • 13 Hardy KJ. Liver surgery: the past 2000 years. Aust N Z J Surg 1990; 60 (10) 811-817
    CrossrefPubMedGoogle Scholar
  • 14 Foster JH. History of liver surgery. Arch Surg 1991; 126 (03) 381-387
    CrossrefPubMedGoogle Scholar
  • 15 Lortat-Jacob JL, Robert HG. Well defined technic for right hepatectomy. Presse Med 1952; 60 (26) 549-551
    PubMedGoogle Scholar
  • 16 Seneque J, Roux M, Chatelin C, Huguenard P. A case of typical left controlled hepatectomy for multiple hydatid cysts of the left part of the liver. Mem Acad Chir (Paris) 1952; 78 (25-26): 728-733
    PubMedGoogle Scholar
  • 17 Latchana N, Peck JR, Whitson BA, Henry ML, Elkhammas EA, Black SM. Preservation solutions used during abdominal transplantation: current status and outcomes. World J Transplant 2015; 5 (04) 154-164
    CrossrefPubMedGoogle Scholar
  • 18 Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659-676
    PubMedGoogle Scholar
  • 19 Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148 (02) 397-401
    CrossrefPubMedGoogle Scholar
  • 20 Ansari D, Andersson R. Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors. World J Gastroenterol 2012; 18 (10) 1003-1008
    CrossrefPubMedGoogle Scholar
  • 21 Shiina S, Tateishi R, Imamura M. , et al. Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors. Liver Int 2012; 32 (09) 1434-1442
    CrossrefPubMedGoogle Scholar
  • 22 Kudo M. Adjuvant therapy after curative treatment for hepatocellular carcinoma. Oncology 2011; 81 (Suppl. 01) 50-55
    PubMedGoogle Scholar
  • 23 El-Serag HB, Siegel AB, Davila JA. , et al. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol 2006; 44 (01) 158-166
    CrossrefPubMedGoogle Scholar
  • 24 Shah SA, Smith JK, Li Y, Ng SC, Carroll JE, Tseng JF. Underutilization of therapy for hepatocellular carcinoma in the Medicare population. Cancer 2011; 117 (05) 1019-1026
    CrossrefPubMedGoogle Scholar
  • 25 Mohanty S, Rajaram R, Bilimoria KY, Salem R, Pawlik TM, Bentrem DJ. Assessment of non-surgical versus surgical therapy for localized hepatocellular carcinoma. J Surg Oncol 2016; 113 (02) 175-180
    CrossrefPubMedGoogle Scholar
  • 26 Dodson RM, He J, Pawlik TM. Resection and transplantation for hepatocellular carcinoma: factors influencing surgical options. Future Oncol 2014; 10 (04) 587-607
    CrossrefPubMedGoogle Scholar
  • 27 Marelli L, Stigliano R, Triantos C. , et al. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev 2006; 32 (08) 594-606
    CrossrefPubMedGoogle Scholar
  • 28 Bellavance EC, Lumpkins KM, Mentha G. , et al. Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?. J Gastrointest Surg 2008; 12 (10) 1699-1708
    CrossrefPubMedGoogle Scholar
  • 29 Santambrogio R, Kluger MD, Costa M. , et al. Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?. HPB (Oxford) 2013; 15 (01) 78-84
    CrossrefPubMedGoogle Scholar
  • 30 Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986; 10 (05) 803-808
    CrossrefPubMedGoogle Scholar
  • 31 Vauthey JN, Dixon E, Abdalla EK. , et al; American Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 2010; 12 (05) 289-299
    CrossrefPubMedGoogle Scholar
  • 32 Abulkhir A, Limongelli P, Healey AJ. , et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008; 247 (01) 49-57
    CrossrefPubMedGoogle Scholar
  • 33 Pawlik TM, Poon RT, Abdalla EK. , et al; International Cooperative Study Group on Hepatocellular Carcinoma. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 2005; 140 (05) 450-457 , discussion 457–458
    CrossrefPubMedGoogle Scholar
  • 34 Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 1993; 40 (04) 328-332
    PubMedGoogle Scholar
  • 35 Pawlik TM, Poon RT, Abdalla EK. , et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 2005; 137 (04) 403-410
    CrossrefPubMedGoogle Scholar
  • 36 Ikai I, Yamamoto Y, Yamamoto N. , et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am 2003; 12 (01) 65-75 , ix
    CrossrefPubMedGoogle Scholar
  • 37 Wakai T, Shirai Y, Sakata J. , et al. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 2007; 14 (04) 1356-1365
    CrossrefPubMedGoogle Scholar
  • 38 Eguchi S, Kanematsu T, Arii S. , et al; Liver Cancer Study Group of Japan. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008; 143 (04) 469-475
    CrossrefPubMedGoogle Scholar
  • 39 Kobayashi A, Miyagawa S, Miwa S, Nakata T. Prognostic impact of anatomical resection on early and late intrahepatic recurrence in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2008; 15 (05) 515-521
    CrossrefPubMedGoogle Scholar
  • 40 Lafaro K, Grandhi MS, Herman JM, Pawlik TM. The importance of surgical margins in primary malignancies of the liver. J Surg Oncol 2016; 113 (03) 296-303
    CrossrefPubMedGoogle Scholar
  • 41 Lee KT, Wang SN, Su RW. , et al. Is wider surgical margin justified for better clinical outcomes in patients with resectable hepatocellular carcinoma?. J Formos Med Assoc 2012; 111 (03) 160-170
    CrossrefPubMedGoogle Scholar
  • 42 Shi M, Guo RP, Lin XJ. , et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 2007; 245 (01) 36-43
    CrossrefPubMedGoogle Scholar
  • 43 Yao FY, Ferrell L, Bass NM. , et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33 (06) 1394-1403
    CrossrefPubMedGoogle Scholar
  • 44 Kamath PS, Wiesner RH, Malinchoc M. , et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33 (02) 464-470
    CrossrefPubMedGoogle Scholar
  • 45 Feng K, Yan J, Li X. , et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 2012; 57 (04) 794-802
    CrossrefPubMedGoogle Scholar
  • 46 Chen MS, Li JQ, Zheng Y. , et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243 (03) 321-328
    CrossrefPubMedGoogle Scholar
  • 47 Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012; 262 (02) 689-700
    CrossrefPubMedGoogle Scholar
  • 48 Maluccio M, Covey AM, Gandhi R. , et al. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. J Vasc Interv Radiol 2005; 16 (07) 955-961
    CrossrefPubMedGoogle Scholar
  • 49 Yamakado K, Nakatsuka A, Takaki H. , et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008; 247 (01) 260-266
    CrossrefPubMedGoogle Scholar
  • 50 Bruix J, Takayama T, Mazzaferro V. , et al; STORM investigators. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Oncol 2015; 16 (13) 1344-1354
    CrossrefPubMedGoogle Scholar
  • 51 Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13 (9, Pt 2): S211-S221
    CrossrefPubMedGoogle Scholar
  • 52 Salem R, Lewandowski RJ, Mulcahy MF. , et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2010; 138 (01) 52-64
    CrossrefPubMedGoogle Scholar
  • 53 Pawlik TM, Reyes DK, Cosgrove D, Kamel IR, Bhagat N, Geschwind JF. Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. J Clin Oncol 2011; 29 (30) 3960-3967
    CrossrefPubMedGoogle Scholar
  • 54 Kneuertz PJ, Cosgrove DP, Cameron AM. , et al. Multidisciplinary management of recurrent hepatocellular carcinoma following liver transplantation. J Gastrointest Surg 2012; 16 (04) 874-881
    CrossrefPubMedGoogle Scholar
  • 55 Roayaie S, Schwartz JD, Sung MW. , et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004; 10 (04) 534-540
    CrossrefPubMedGoogle Scholar
  • 56 Schwartz M, Roayaie S, Llovet J. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?. J Hepatol 2005; 43 (04) 584-589
    CrossrefPubMedGoogle Scholar
  • 57 Kornberg A, Küpper B, Tannapfel A. , et al. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Eur J Surg Oncol 2010; 36 (03) 275-280
    CrossrefPubMedGoogle Scholar
  • 58 Shin WY, Suh KS, Lee HW. , et al. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2010; 16 (05) 678-684
    CrossrefPubMedGoogle Scholar
  • 59 Cunningham SC, Tsai S, Marques HP. , et al. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis. Ann Surg Oncol 2009; 16 (07) 1820-1831
    CrossrefPubMedGoogle Scholar
  • 60 Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30 (06) 1434-1440
    CrossrefPubMedGoogle Scholar
  • 61 Belghiti J, Cortes A, Abdalla EK. , et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238 (06) 885-892 , discussion 892–893
    CrossrefPubMedGoogle Scholar
  • 62 Sala M, Fuster J, Llovet JM. , et al; Barcelona Clinic Liver Cancer (BCLC) Group. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl 2004; 10 (10) 1294-1300
    CrossrefPubMedGoogle Scholar
  • 63 Del Gaudio M, Ercolani G, Ravaioli M. , et al. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant 2008; 8 (06) 1177-1185
    CrossrefPubMedGoogle Scholar
  • 64 Lau WY, Lai EC, Lau SH. The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review. Hepatobiliary Pancreat Dis Int 2009; 8 (02) 124-133
    PubMedGoogle Scholar
  • 65 Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232 (01) 10-24
    CrossrefPubMedGoogle Scholar
  • 66 Zhou WP, Lai EC, Li AJ. , et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009; 249 (02) 195-202
    CrossrefPubMedGoogle Scholar
  • 67 Harada T, Matsuo K, Inoue T, Tamesue S, Inoue T, Nakamura H. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?. Ann Surg 1996; 224 (01) 4-9
    CrossrefPubMedGoogle Scholar
  • 68 Okamura J, Horikawa S, Fujiyama T. , et al. An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg 1982; 6 (03) 352-357
    CrossrefPubMedGoogle Scholar
  • 69 Goel M, Gaikwad V, Dharia T, Kulkarni S, Shetty N, Shrikhande SV. Preresection transarterial chemoembolization for hepatocellular carcinoma: an experience with 23 patients. Indian J Gastroenterol 2014; 33 (05) 432-439
    CrossrefPubMedGoogle Scholar
  • 70 Di Carlo V, Ferrari G, Castoldi R. , et al. Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 1998; 45 (24) 1950-1954
    PubMedGoogle Scholar
  • 71 Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000; 89 (12) 2606-2612
    CrossrefPubMedGoogle Scholar
  • 72 Luo YQ, Wang Y, Chen H, Wu MC. Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2002; 1 (04) 523-526
    PubMedGoogle Scholar
  • 73 Majno PE, Adam R, Bismuth H. , et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226 (06) 688-701 , discussion 701–703
    CrossrefPubMedGoogle Scholar
  • 74 Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, P'eng FK. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995; 82 (01) 122-126
    CrossrefPubMedGoogle Scholar
  • 75 Yamasaki S, Hasegawa H, Kinoshita H. , et al. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 1996; 87 (02) 206-211
    CrossrefPubMedGoogle Scholar
  • 76 Gao ZH, Bai DS, Jiang GQ, Jin SJ. Review of preoperative transarterial chemoembolization for resectable hepatocellular carcinoma. World J Hepatol 2015; 7 (01) 40-43
    CrossrefPubMedGoogle Scholar
  • 77 Chua TC, Liauw W, Saxena A. , et al. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma. Liver Int 2010; 30 (02) 166-174
    CrossrefPubMedGoogle Scholar
  • 78 Zhou Y, Zhang X, Wu L. , et al. Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma. BMC Gastroenterol 2013; 13: 51
    CrossrefPubMedGoogle Scholar
  • 79 Lau WY, Yu SC, Lai EC, Leung TW. Transarterial chemoembolization for hepatocellular carcinoma. J Am Coll Surg 2006; 202 (01) 155-168
    CrossrefPubMedGoogle Scholar
  • 80 Fan J, Tang ZY, Yu YQ. , et al. Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. Dig Surg 1998; 15 (06) 674-678
    CrossrefPubMedGoogle Scholar
  • 81 Takenaka K, Yoshida K, Nishizaki T. , et al. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 1995; 169 (04) 400-404 , discussion 405
    CrossrefPubMedGoogle Scholar
  • 82 Nonami T, Isshiki K, Katoh H. , et al. The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas. Ann Surg 1991; 213 (03) 222-226
    CrossrefPubMedGoogle Scholar
  • 83 Li JQ, Zhang YQ, Zhang WZ, Yuan YF, Li GH. Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin Oncol 1995; 121 (06) 364-366
    CrossrefPubMedGoogle Scholar
  • 84 Cheng HY, Wang X, Chen D, Xu AM, Jia YC. The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma. World J Gastroenterol 2005; 11 (23) 3644-3646
    CrossrefPubMedGoogle Scholar
  • 85 Ono T, Nagasue N, Kohno H. , et al. Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study. Semin Oncol 1997; 24 (02) (Suppl. 06) S6-S18 , S6–S25
    PubMedGoogle Scholar
  • 86 Kohno H, Nagasue N, Hayashi T. , et al. Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC). Hepatogastroenterology 1996; 43 (12) 1405-1409
    PubMedGoogle Scholar
  • 87 Zhu SL, Zhong JH, Ke Y. , et al. Comparative efficacy of postoperative transarterial chemoembolization with or without antiviral therapy for hepatitis B virus-related hepatocellular carcinoma. Tumour Biol 2015; 36 (08) 6277-6284
    CrossrefPubMedGoogle Scholar
  • 88 Liu C, Sun L, Xu J, Zhao Y. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma. World J Surg Oncol 2016; 14: 100
    CrossrefPubMedGoogle Scholar
  • 89 Izumi R, Shimizu K, Iyobe T. , et al. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 1994; 20 (02) 295-301
    CrossrefPubMedGoogle Scholar
  • 90 Gong WF, Zhong JH, Xiang BD, Li LQ. Feasibility of combining adjuvant transarterial chemoembolization with nucleos(t)ide analog therapy for patients with HBV-associated hepatocellular carcinoma after hepatectomy. Mol Clin Oncol 2016; 5 (01) 3-6
    CrossrefPubMedGoogle Scholar
  • 91 Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev 2009; (01) CD001199
    PubMedGoogle Scholar
  • 92 Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 2002; 3 (10) 593-603
    CrossrefPubMedGoogle Scholar
  • 93 Wang J, He XD, Yao N, Liang WJ, Zhang YC. A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma. Can J Gastroenterol 2013; 27 (06) 351-363
    CrossrefPubMedGoogle Scholar
  • 94 Jiang S, Liu Y, Wang L, Duan C, Liu M. A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma. World J Surg Oncol 2013; 11: 240
    CrossrefPubMedGoogle Scholar
  • 95 Kishi Y, Saiura A, Yamamoto J. , et al. Repeat treatment for recurrent hepatocellular carcinoma: is it validated?. Langenbecks Arch Surg 2011; 396 (07) 1093-1100
    CrossrefPubMedGoogle Scholar
  • 96 Thomasset SC, Dennison AR, Garcea G. Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors. World J Surg 2015; 39 (05) 1150-1160
    CrossrefPubMedGoogle Scholar
  • 97 Choi D, Lim HK, Rhim H. , et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol 2007; 14 (08) 2319-2329
    CrossrefPubMedGoogle Scholar
  • 98 Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229 (02) 216-222
    CrossrefPubMedGoogle Scholar
  • 99 Cheng YC, Chen TW, Fan HL, Yu CY, Chang HC, Hsieh CB. Transarterial chemoembolization for intrahepatic multiple recurrent HCC after liver resection or transplantation. Ann Transplant 2014; 19: 309-316
    CrossrefPubMedGoogle Scholar
  • 100 Koh PS, Chan AC, Cheung TT. , et al. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis. HPB (Oxford) 2016; 18 (01) 72-78
    CrossrefPubMedGoogle Scholar
  • 101 Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S, Mori M. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol 2006; 32 (07) 773-779
    CrossrefPubMedGoogle Scholar
  • 102 Xi T, Lai EC, Min AR. , et al. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study. Hepatogastroenterology 2012; 59 (116) 1198-1203
    PubMedGoogle Scholar
  • 103 Asahara T, Itamoto T, Katayama K. , et al. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up. Hepatogastroenterology 1999; 46 (26) 1042-1048
    PubMedGoogle Scholar
  • 104 Jiang JH, Guo Z, Lu HF. , et al. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis. World J Gastroenterol 2015; 21 (15) 4627-4634
    CrossrefPubMedGoogle Scholar
  • 105 Lai EC, Lo CM, Fan ST, Liu CL, Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 1998; 133 (02) 183-188
    PubMedGoogle Scholar
  • 106 Peng BG, He Q, Li JP, Zhou F. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg 2009; 198 (03) 313-318
    CrossrefPubMedGoogle Scholar